Predictive Value of Apelin-36 for No-Reflow Phenomenon in STEMI Patients [PDF]
LifeBackground: In patients with ST-segment elevation myocardial infarction (STEMI), apelin is upregulated and exerts cardioprotective effects against ischemia–reperfusion injury (IRI).
Xhevdet Krasniqi +9 more
doaj +2 more sources
The triglyceride–glucose index is associated with no-reflow phenomenon in STEMI patients with type 2 diabetes after percutaneous coronary intervention [PDF]
Frontiers in Cardiovascular MedicineBackgroundThe relationship between the triglyceride–glucose (TyG) index and no-reflow phenomenon after percutaneous coronary intervention (PCI) in patients with type 2 diabetes mellitus (T2DM) and acute ST-segment elevation myocardial infarction (STEMI ...
Juan Ma +6 more
doaj +2 more sources
Utility of electrocardiogram to predict the occurrence of the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention (PPCI): a systematic review and meta-analysis [PDF]
Frontiers in Cardiovascular Medicine, 2023 BackgroundThe no-reflow phenomenon affects about one out of five patients undergoing Primary Percutaneous Coronary Intervention (PPCI). As the prolonged no-reflow phenomenon is linked with unfavorable outcomes, making early recognition is crucial for ...
Elmira Jafari Afshar +7 more
doaj +2 more sources
A Machine Learning Model for the Prediction of No-Reflow Phenomenon in Acute Myocardial Infarction Using the CALLY Index [PDF]
DiagnosticsBackground: Acute myocardial infarction (AMI) constitutes a major health problem with high mortality rates worldwide. In patients with ST-segment elevation myocardial infarction (STEMI), no-reflow phenomenon is a condition that adversely affects response
Halil Fedai +8 more
doaj +2 more sources
Does Adjunctive Prophylactic Intracoronary Infusion of Low Dose Alteplase Prevent No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention? [PDF]
ARYA Atherosclerosis, 2023 INTRODUCTION: Primary percutaneous coronary intervention (PPCI) is the gold standard approach to restore blood flow in ST-segment elevation myocardial infarction (STEMI); however, the no-reflow phenomenon as a potential complication of PPCI can worsen ...
Mohammad Hashemi +5 more
doaj +2 more sources
International Journal of Cardiology: Heart & Vasculature, 2022 Background: The release of lipid-laden plaque material subsequent to ST-segment elevation myocardial infarction (STEMI) may contribute to the no-reflow phenomenon.
Yosuke Katayama +8 more
doaj +1 more source
Global Heart, 2022 Background: Stress hyperglycemia is a common finding during acute myocardial infarction and associated with poor prognosis. To reduce the occurrence of no-reflow, prognostic factors must be identified before primary percutaneous coronary intervention ...
Mohamed Khalfallah +2 more
doaj +1 more source
Treatment Outcomes in STEMI Patients With No/Slow-Reflow Phenomenon, Depending on Age
Инновационная медицина Кубани, 2023 Objective: To assess the risks of no/slow-reflow phenomena and treatment outcomes in patients with ST-segment elevation myocardial infarction (STEMI) from different age groups.Materials and methods: We analyzed treatment outcomes of 535 STEMI patients ...
G. V. Sazanov +4 more
doaj +1 more source
Bagcilar Medical Bulletin, 2023 Objective: No-reflow phenomenon is one of well-known complications of percutaneous coronary intervention (PCI). The rate of no-reflow phenomenon was reported between 2-44% differing on the accompanying situations and more frequent in acute myocardial ...
Esra Dönmez +3 more
doaj +1 more source
Comparison of RCHA2DS2-VASc Score and CHA2DS2-VASc Score for Prediction of No-Reflow Phenomenon in Patients with ST-Segment Elevation Myocardial Infarction undergoing Primary Percutaneous Coronary Intervention. [PDF]
Al-Azhar International Medical Journal, 2023 Background: During primary PCI, about 95% of blocked coronary vessels are reopened. Therefore, it is the best applicable reperfusion strategy for acute STEMI.
Ahmed Ibrahim Elsherif +2 more
doaj +1 more source